320 related articles for article (PubMed ID: 29165714)
1. Blood lipid genetic scores, the HMGCR gene and cancer risk: a Mendelian randomization study.
Orho-Melander M; Hindy G; Borgquist S; Schulz CA; Manjer J; Melander O; Stocks T
Int J Epidemiol; 2018 Apr; 47(2):495-505. PubMed ID: 29165714
[TBL] [Abstract][Full Text] [Related]
2. Association between genetically proxied HMGCR inhibition and male reproductive health: A Mendelian randomization study.
Yan Z; Xu Y; Li K; Liu L
Medicine (Baltimore); 2023 Sep; 102(39):e34690. PubMed ID: 37773823
[TBL] [Abstract][Full Text] [Related]
3. Blood lipids and prostate cancer: a Mendelian randomization analysis.
Bull CJ; Bonilla C; Holly JM; Perks CM; Davies N; Haycock P; Yu OH; Richards JB; Eeles R; Easton D; Kote-Jarai Z; Amin Al Olama A; Benlloch S; Muir K; Giles GG; MacInnis RJ; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Micheal A; Pandha H; Smith GD; Lewis SJ; Martin RM;
Cancer Med; 2016 Jun; 5(6):1125-36. PubMed ID: 26992435
[TBL] [Abstract][Full Text] [Related]
4. Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study.
Ference BA; Majeed F; Penumetcha R; Flack JM; Brook RD
J Am Coll Cardiol; 2015 Apr; 65(15):1552-61. PubMed ID: 25770315
[TBL] [Abstract][Full Text] [Related]
5. Mendelian Randomization Study of
Ference BA; Ray KK; Catapano AL; Ference TB; Burgess S; Neff DR; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Kastelein JJP; Nicholls SJ
N Engl J Med; 2019 Mar; 380(11):1033-1042. PubMed ID: 30865797
[TBL] [Abstract][Full Text] [Related]
6. A Mendelian Randomization Approach Using 3-HMG-Coenzyme-A Reductase Gene Variation to Evaluate the Association of Statin-Induced Low-Density Lipoprotein Cholesterol Lowering With Noncardiovascular Disease Phenotypes.
Liu G; Shi M; Mosley JD; Weng C; Zhang Y; Lee MTM; Jarvik GP; Hakonarson H; Namjou-Khales B; Sleiman P; Luo Y; Mentch F; Denny JC; Linton MF; Wei WQ; Stein CM; Feng Q
JAMA Netw Open; 2021 Jun; 4(6):e2112820. PubMed ID: 34097045
[TBL] [Abstract][Full Text] [Related]
7. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.
Swerdlow DI; Preiss D; Kuchenbaecker KB; Holmes MV; Engmann JE; Shah T; Sofat R; Stender S; Johnson PC; Scott RA; Leusink M; Verweij N; Sharp SJ; Guo Y; Giambartolomei C; Chung C; Peasey A; Amuzu A; Li K; Palmen J; Howard P; Cooper JA; Drenos F; Li YR; Lowe G; Gallacher J; Stewart MC; Tzoulaki I; Buxbaum SG; van der A DL; Forouhi NG; Onland-Moret NC; van der Schouw YT; Schnabel RB; Hubacek JA; Kubinova R; Baceviciene M; Tamosiunas A; Pajak A; Topor-Madry R; Stepaniak U; Malyutina S; Baldassarre D; Sennblad B; Tremoli E; de Faire U; Veglia F; Ford I; Jukema JW; Westendorp RG; de Borst GJ; de Jong PA; Algra A; Spiering W; Maitland-van der Zee AH; Klungel OH; de Boer A; Doevendans PA; Eaton CB; Robinson JG; Duggan D; ; ; ; Kjekshus J; Downs JR; Gotto AM; Keech AC; Marchioli R; Tognoni G; Sever PS; Poulter NR; Waters DD; Pedersen TR; Amarenco P; Nakamura H; McMurray JJ; Lewsey JD; Chasman DI; Ridker PM; Maggioni AP; Tavazzi L; Ray KK; Seshasai SR; Manson JE; Price JF; Whincup PH; Morris RW; Lawlor DA; Smith GD; Ben-Shlomo Y; Schreiner PJ; Fornage M; Siscovick DS; Cushman M; Kumari M; Wareham NJ; Verschuren WM; Redline S; Patel SR; Whittaker JC; Hamsten A; Delaney JA; Dale C; Gaunt TR; Wong A; Kuh D; Hardy R; Kathiresan S; Castillo BA; van der Harst P; Brunner EJ; Tybjaerg-Hansen A; Marmot MG; Krauss RM; Tsai M; Coresh J; Hoogeveen RC; Psaty BM; Lange LA; Hakonarson H; Dudbridge F; Humphries SE; Talmud PJ; Kivimäki M; Timpson NJ; Langenberg C; Asselbergs FW; Voevoda M; Bobak M; Pikhart H; Wilson JG; Reiner AP; Keating BJ; Hingorani AD; Sattar N
Lancet; 2015 Jan; 385(9965):351-61. PubMed ID: 25262344
[TBL] [Abstract][Full Text] [Related]
8. Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer.
Gao C; Patel CJ; Michailidou K; Peters U; Gong J; Schildkraut J; Schumacher FR; Zheng W; Boffetta P; Stucker I; Willett W; Gruber S; Easton DF; Hunter DJ; Sellers TA; Haiman C; Henderson BE; Hung RJ; Amos C; Pierce BL; Lindström S; Kraft P;
Int J Epidemiol; 2016 Jun; 45(3):896-908. PubMed ID: 27427428
[TBL] [Abstract][Full Text] [Related]
9. Association of HMGCR inhibition with rheumatoid arthritis: a Mendelian randomization and colocalization study.
Ma L; Du Y; Ma C; Liu M
Front Endocrinol (Lausanne); 2023; 14():1272167. PubMed ID: 38047111
[TBL] [Abstract][Full Text] [Related]
10. Low LDL cholesterol,
Benn M; Nordestgaard BG; Frikke-Schmidt R; Tybjærg-Hansen A
BMJ; 2017 Apr; 357():j1648. PubMed ID: 28438747
[No Abstract] [Full Text] [Related]
11. Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer.
Rodriguez-Broadbent H; Law PJ; Sud A; Palin K; Tuupanen S; Gylfe A; Hänninen UA; Cajuso T; Tanskanen T; Kondelin J; Kaasinen E; Sarin AP; Ripatti S; Eriksson JG; Rissanen H; Knekt P; Pukkala E; Jousilahti P; Salomaa V; Palotie A; Renkonen-Sinisalo L; Lepistö A; Böhm J; Mecklin JP; Al-Tassan NA; Palles C; Martin L; Barclay E; Farrington SM; Timofeeva MN; Meyer BF; Wakil SM; Campbell H; Smith CG; Idziaszczyk S; Maughan TS; Kaplan R; Kerr R; Kerr D; Passarelli MN; Figueiredo JC; Buchanan DD; Win AK; Hopper JL; Jenkins MA; Lindor NM; Newcomb PA; Gallinger S; Conti D; Schumacher F; Casey G; Aaltonen LA; Cheadle JP; Tomlinson IP; Dunlop MG; Houlston RS
Int J Cancer; 2017 Jun; 140(12):2701-2708. PubMed ID: 28340513
[TBL] [Abstract][Full Text] [Related]
12. Genetically-predicted life-long lowering of low-density lipoprotein cholesterol is associated with decreased frailty: A Mendelian randomization study in UK biobank.
Wang Q; Wang Y; Lehto K; Pedersen NL; Williams DM; Hägg S
EBioMedicine; 2019 Jul; 45():487-494. PubMed ID: 31300347
[TBL] [Abstract][Full Text] [Related]
13. A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study.
Donnelly LA; Doney AS; Dannfald J; Whitley AL; Lang CC; Morris AD; Donnan PT; Palmer CN
Pharmacogenet Genomics; 2008 Dec; 18(12):1021-6. PubMed ID: 18815589
[TBL] [Abstract][Full Text] [Related]
14. Potential causal associations of serum 25-hydroxyvitamin D with lipids: a Mendelian randomization approach of the HUNT study.
Mai XM; Videm V; Sheehan NA; Chen Y; Langhammer A; Sun YQ
Eur J Epidemiol; 2019 Jan; 34(1):57-66. PubMed ID: 30465296
[TBL] [Abstract][Full Text] [Related]
15. Mendelian randomization of blood lipids for coronary heart disease.
Holmes MV; Asselbergs FW; Palmer TM; Drenos F; Lanktree MB; Nelson CP; Dale CE; Padmanabhan S; Finan C; Swerdlow DI; Tragante V; van Iperen EP; Sivapalaratnam S; Shah S; Elbers CC; Shah T; Engmann J; Giambartolomei C; White J; Zabaneh D; Sofat R; McLachlan S; ; Doevendans PA; Balmforth AJ; Hall AS; North KE; Almoguera B; Hoogeveen RC; Cushman M; Fornage M; Patel SR; Redline S; Siscovick DS; Tsai MY; Karczewski KJ; Hofker MH; Verschuren WM; Bots ML; van der Schouw YT; Melander O; Dominiczak AF; Morris R; Ben-Shlomo Y; Price J; Kumari M; Baumert J; Peters A; Thorand B; Koenig W; Gaunt TR; Humphries SE; Clarke R; Watkins H; Farrall M; Wilson JG; Rich SS; de Bakker PI; Lange LA; Davey Smith G; Reiner AP; Talmud PJ; Kivimäki M; Lawlor DA; Dudbridge F; Samani NJ; Keating BJ; Hingorani AD; Casas JP
Eur Heart J; 2015 Mar; 36(9):539-50. PubMed ID: 24474739
[TBL] [Abstract][Full Text] [Related]
16. Predicting the effect of statins on cancer risk using genetic variants from a Mendelian randomization study in the UK Biobank.
Carter P; Vithayathil M; Kar S; Potluri R; Mason AM; Larsson SC; Burgess S
Elife; 2020 Oct; 9():. PubMed ID: 33046214
[TBL] [Abstract][Full Text] [Related]
17. Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis.
Proitsi P; Lupton MK; Velayudhan L; Newhouse S; Fogh I; Tsolaki M; Daniilidou M; Pritchard M; Kloszewska I; Soininen H; Mecocci P; Vellas B; ; Williams J; ; Stewart R; Sham P; Lovestone S; Powell JF
PLoS Med; 2014 Sep; 11(9):e1001713. PubMed ID: 25226301
[TBL] [Abstract][Full Text] [Related]
18. A Mendelian randomization analysis of circulating lipid traits and breast cancer risk.
Beeghly-Fadiel A; Khankari NK; Delahanty RJ; Shu XO; Lu Y; Schmidt MK; Bolla MK; Michailidou K; Wang Q; Dennis J; Yannoukakos D; Dunning AM; Pharoah PDP; Chenevix-Trench G; Milne RL; Hunter DJ; Per H; Kraft P; Simard J; Easton DF; Zheng W
Int J Epidemiol; 2020 Aug; 49(4):1117-1131. PubMed ID: 31872213
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase.
Würtz P; Wang Q; Soininen P; Kangas AJ; Fatemifar G; Tynkkynen T; Tiainen M; Perola M; Tillin T; Hughes AD; Mäntyselkä P; Kähönen M; Lehtimäki T; Sattar N; Hingorani AD; Casas JP; Salomaa V; Kivimäki M; Järvelin MR; Davey Smith G; Vanhala M; Lawlor DA; Raitakari OT; Chaturvedi N; Kettunen J; Ala-Korpela M
J Am Coll Cardiol; 2016 Mar; 67(10):1200-1210. PubMed ID: 26965542
[TBL] [Abstract][Full Text] [Related]
20. Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs: A Mendelian Randomization Study.
Alghamdi J; Matou-Nasri S; Alghamdi F; Alghamdi S; Alfadhel M; Padmanabhan S
Int J Neuropsychopharmacol; 2018 Dec; 21(12):1067-1075. PubMed ID: 29986042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
